Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
ZAK-IN-2
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | ZAK-IN-2 (Compound 8) is a selective covalent inhibitor of ZAK with an IC50 of 11.5 nM. It forms a covalent bond with Cys22 in the ZAKP loop, thereby inhibiting its kinase activity. ZAK-IN-2 also suppresses the phosphorylation of the downstream target p38 and can block Doxorubicin-induced Caspase 3 cleavage. This compound may be utilized in research related to myocardial hypertrophy. |
| In vitro | ZAK-IN-2 effectively inhibits recombinant ZAK kinase with an IC50 of 11.5 nM, demonstrating high selectivity compared to B-raf V600E. ZAK-IN-2 (0.01-10 μM; 1 h) also dose-dependently inhibits ZAKα kinase activity in U2OS cells, as evidenced by the decreased phosphorylation levels of downstream p38. |
| Molecular Weight | 668.67 |
| Formula | C33H26F2N8O4S |
| Cas No. | 3033697-19-4 |
| Smiles | O=C(C=C)N1CCC(OC2=NNC=3N=CC(=CC23)C=4N=NN(C4)C=5C(F)=CC=C(NS(=O)(=O)C6=CC=CC(=C6)C=7C=CC=CC7)C5F)C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.